European pharma pays $1.5bn to US doctors

Roche and GSK among Europe’s biggest spenders last year

Wearables craze: The Fitbit watch

Feedback: Lucy Kellaway on step-counters

Readers were irked at the attack on a tool for keeping fit


Aetna to buy Humana for $37bn

Merger creates second-biggest US managed care group


Gene therapy offers cystic fibrosis hope

Positive results achieved in treating people with killer disease

GSK agrees China tie-up for HIV drugs

Deal suggests UK group is beginning to rebuild reputation

NHS medicines to be labelled with price

Health secretary proposes slogan: ‘Funded by the UK taxpayer’

Animal health jumps up the pharma agenda

Farming and rising pet ownership fuel interest in niche sector

Celgene places $1bn bet on biotech Juno

Investment is close to 100% premium to Monday’s close

Warning on threat to Greek drug supplies

Fears grow that euro exit would disrupt supplies

Samsung: similar outcome

A heady valuation for its biosimilars business may be intended to sweeten merger terms

Fasting plus cardio sheds weight quicker

Cutting down calories on alternate days and undertaking endurance exercise produces striking results

InFrontier takes stake in Afghan pharmacy

UK group says deal shows the country is opening to business

Eli Lilly and Immunocore to collaborate

US and UK pharma groups aim to develop combination cancer therapies

Samsung Bioepis eyes Nasdaq listing

South Korean company targets valuation of at least $8bn

Geneticists’ quest for crisper prose

Deleting disease at genome level calls for contemplation

Teijin spooks mosquitoes and woos buyers

Fear of dengue fever in Japan lift sales of wonder fabric but regulations could stunt global growth

African trials fuel malaria vaccine hopes

Equatorial Guinea hosts tests that hold promise of end to disease

Drones get a new mission: saving lives

Unmanned aerial vehicles gain civilian as well as military uses

Private equity eyes N Africa healthcare

Citizens are spending more on medical services

US Supreme Court upholds Obamacare subsidies

Major victory for president on key part of health reforms


More FT Twitter accounts